The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Berenberg cuts Rio Tinto and BofA lowers Anto

Thu, 07th Jul 2022 10:30

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

Berenberg cuts Admiral price target to 2,903 (3,462) pence - 'buy'

----------

Goldman Sachs cuts Admiral price target to 2,450 (2,650) pence - 'sell'

----------

JPMorgan cuts Hargreaves Lansdown target to 770 (1,060) pence - 'underweight'

----------

Credit Suisse cuts London Stock Exchange Group price target to 8,900 (9,000)

----------

Bank of America cuts Persimmon price target to 3,000 (3,100) pence - 'buy'

----------

JPMorgan cuts Persimmon price target to 3,060 (3,110) pence - 'overweight'

----------

Bank of America cuts Rio Tinto price target to 6,700 (7,200) pence - 'buy'

----------

Berenberg cuts Rio Tinto to 'sell' (hold) - price target 4,200 (6,500) pence - 'outperform'

----------

Bank of America cuts Glencore price target to 470 (530) pence - 'neutral'

----------

Bank of America cuts Fresnillo price target to 920 (990) pence - 'buy'

----------

Bank of America cuts Anglo American price target to 3,000 (4,200) pence - 'neutral'

----------

Berenberg cuts Anglo American price target to 3,300 (4,000) pence - 'buy'

----------

Bank of America cuts Antofagasta to 'underperform' (buy) - price target 1,000 (1,700) pence

----------

Bank of America cuts CRH price target to 4,000 (4,700) pence - 'buy'

----------

Bank of America cuts Ashtead Group price target to 6,500 (8,000) pence - 'buy'

----------

Morgan Stanley cuts Vodafone price target to 180 (190) pence - 'overweight'

----------

Morgan Stanley cuts WPP price target to 750 (850) pence - 'underweight'

----------

Jefferies raises AstraZeneca price target to 9,800 (9,500) pence - 'hold'

----------

FTSE 250

----------

Bank of America cuts Travis Perkins price target to 1,650 (2,000) pence - 'buy'

----------

Bank of America cuts Hochschild Mining price target to 130 (140) pence - 'buy'

----------

Berenberg cuts Hochschild Mining price target to 150 (160) pence - 'buy'

----------

Bank of America cuts Ferrexpo price target to 150 (160) pence - 'underperform'

----------

Bank of America raises Centamin price target to 140 (130) pence - 'buy'

----------

Berenberg cuts Centamin price target to 112 (114) pence - 'buy'

----------

Morgan Stanley raises Drax Group price target to 1,010 (1,000) pence - 'overweight'

----------

RBC raises Drax Group price target to 1,175 (1,150) pence - 'outperform'

----------

JPMorgan raises Drax Group price target to 990 (975) pence - 'overweight'

----------

Jefferies cuts Johnson Matthey price target to 2,400 (2,600) pence - 'buy'

----------

Morgan Stanley raises Lancashire price target to 441 (434) pence - 'underweight'

----------

Berenberg cuts Direct Line price target to 277 (306) pence - 'hold'

----------

Goldman Sachs cuts Direct Line price target to 340 (370) pence - 'buy'

----------

Liberum raises Trainline price target to 470 (435) pence - 'buy'

----------

Deutsche Bank raises Trainline price target to 371 (319) pence - 'hold'

----------

SMALL CAP

----------

Bank of America cuts Kingspan price target to 90 (105) EUR - 'buy'

----------

Bank of America cuts Ferguson price target to 12,000 (14,000) pence - 'buy'

----------

Bank of America cuts Atalaya Mining to 'neutral' (buy) - price target 320 (520) pence

----------

Berenberg cuts Atalaya Mining price target to 430 (500) pence - 'buy'

----------

Bank of America cuts Anglo Pacific price target to 220 (230) pence - 'buy'

----------

Berenberg raises Anglo Pacific price target to 450 (300) pence - 'buy'

----------

Berenberg raises Tharisa price target to 280 (250) pence - 'buy'

----------

Berenberg raises Sovereign Metals price target to 75 (74) pence - 'buy'

----------

Berenberg cuts Pan African Resources price target to 31 (33) pence - 'buy'

----------

Berenberg raises Kenmare Resources price target to 750 (670) pence - 'buy'

----------

Berenberg cuts Jubilee Metals price target to 20 (22) pence - 'buy'

----------

Berenberg cuts Griffin Mining price target to 160 (175) pence - 'buy'

----------

Berenberg cuts Greatland Gold price target to 22 (26) pence - 'buy'

----------

Berenberg cuts Central Asia Metals price target to 310 (340) pence - 'buy'

----------

Berenberg cuts BHP Group price target to 2,200 (2,700) pence - 'hold'

----------

Jefferies cuts Jet2 price target to 1,650 (1,750) pence - 'buy'

----------

JPMorgan cuts AO World price target to 40 (59) pence - 'underweight'

----------

Jefferies cuts GB Group price target to 450 (1,050) pence - 'buy'

----------

Berenberg cuts Impax Asset Management price target to 1,000 (1,250) pence - 'buy'

----------

Jefferies cuts Hunting price target to 330 (380) pence - 'buy'

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.